Hepcvir L Tablets
In stock
Description
Hepcvir L (manufactured by Cipla) is a prescription antiviral medication containing Ledipasvir (90 mg) and Sofosbuvir (400 mg). It is primarily used to treat chronic Hepatitis C virus (HCV) infections.
Hepcvir L is an allopathic, prescription-only medication composed of a fixed-dose combination of Ledipasvir (NS5A inhibitor) and Sofosbuvir (nucleotide analog polymerase inhibitor). Together, these antiviral agents prevent the Hepatitis C virus from multiplying in the body, helping to clear the infection and allowing the liver to recover. The standard adult dosage is typically one tablet daily, taken for 12 weeks as directed by a healthcare professional.
Specifications
| Active Ingredients | Ledipasvir and Sofosbuvir |
|---|---|
| Drug Class | HCV NS5A Inhibitor |
| Packaging | Typically 28 tablets per bottle/pack |
| Indiaction | Chronic Hepatitis C Virus (HCV) infection treatment |
